In the field of nuclear cardiology we have three imaging modalities to measure ventricular function: first-pass radionuclide angiography (FPRNA), equilibrium gated radionuclide angiography (ERNA), and ECG-gated myocardial perfusion imaging SPECT (GSPECT) or PET studies.1 GSPECT was introduced in the 1980s and is considered an ideal technique for combined evaluation of myocardial perfusion and left ventricular function from a single study.2 Automation of the image processing and quantification has made this technique practical and highly reproducible. In patients with known or suspected coronary artery disease, gating enhances the diagnostic and prognostic capability of myocardial perfusion imaging and provides incremental information over the perfusion data.
3During a GSPECT study, a perfusion tracer is injected and is taken up by the LV myocardium. The definitions of the LV myocardium and the LV cavity are achieved by delineating both the endocardium as well as the epicardial edges on the perfusion image. LV regional and global contractile functions are quantified based on the changes in the LV volume, excursion of the endocardium, and brightening of the myocardium from the ECG-gated end-diastole to end-systole.